scispace - formally typeset
Z

Zia Rehman

Researcher at East Carolina University

Publications -  5
Citations -  111

Zia Rehman is an academic researcher from East Carolina University. The author has contributed to research in topics: Medicine & Genome-wide association study. The author has an hindex of 2, co-authored 3 publications receiving 61 citations.

Papers
More filters
Journal ArticleDOI

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

Christopher J. Rhodes, +117 more
TL;DR: Functional and epigenomic data indicate that the risk variants near SOX17 alter gene regulation via an enhancer active in endothelial cells that determined Pulmonary arterial hypertension risk variants determined haplotype-specific enhancer activity, and CRISPR-mediated inhibition of the enhancer reduced SoX17 expression.
Journal ArticleDOI

Granulocytic sarcoma of the male breast in acute myeloblastic leukemia with concurrent deletion of 5q and trisomy 8

TL;DR: A unique case of Granulocytic Sarcoma in a male, who presented to us with a painless right breast mass without any prior history of Leukemia, is described.

Nocturnal blood pressure assessment, an entity of high prognostic value, not utilized to its potential in clinical practice

TL;DR: In this paper , the authors provide an update on the proposed mechanisms underlying arrhythmogenesis in NAFLD and summarize the latest research findings in this field and recommend a comprehensive approach that includes treating the underlying liver condition and regular ECG monitoring to detect and address any potential cardiac complications.
Posted ContentDOI

Genetic determinants of risk and survival in pulmonary arterial hypertension

Christopher J. Rhodes, +117 more
- 16 May 2018 - 
TL;DR: Functional and epigenomic data indicate that the risk variants near SOX17 alter gene regulation via an enhancer active in endothelial cells that stratifies PAH patients for survival following diagnosis, with implications for future therapeutic trial design.
Journal ArticleDOI

Non-Adherence Factors Associated with the Use of Rivaroxaban Among Patients with Deep Venous Thromboembolism: A Single Center Observational Study

TL;DR: In this paper , an observational longitudinal study was conducted at the Department of Surgery, Aga Khan University & Hospital, Karachi between June 2022 to November 2022 to assess the rate and factors associated with non-adherence of Rivaroxaban in patients with deep venous thrombosis.